Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data validation
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Biomarker clinical phase outsourcing services industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Biomarker type trends
2.1.4 Therapeutic area trends
2.1.5 End-user trends
Chapter 3 Biomarker Clinical Phase Outsourcing Services Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rapid advancements in biomarker technology
3.2.1.2 Increasing use of biomarkers
3.2.1.3 Rising government initiatives and funding
3.2.2 Industry pitfalls & challenges
3.2.2.1 Regulatory compliance
3.3 Growth potential analysis
3.3.1 By biomarker type
3.3.2 By therapeutic area
3.3.3 By end-user
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By Biomarker Type, 2018-2032 (USD Million)
5.1 Key trends, by biomarker type
5.2 Surrogate endpoints
5.3 Predictive biomarker
5.4 Prognostic biomarker
5.5 Safety biomarker
5.6 Other biomarker types
Chapter 6 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By Therapeutic Area, 2018-2032 (USD Million)
6.1 Key trends, by therapeutic area
6.2 Oncology
6.3 Neurology
6.4 Cardiology
6.5 Autoimmune diseases
6.6 Other therapeutic areas
Chapter 7 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)
7.1 Key trends, by end-user
7.2 Pharmaceutical companies
7.3 Biotechnology companies
7.4 Other end-users
Chapter 8 Biomarker Clinical Phase Outsourcing Services Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Laboratory Corporation of America Holdings
9.2 Parexel International Corporation
9.3 Charles River Laboratories International, Inc.
9.4 ICON plc
9.5 Proteome Sciences plc
9.6 Fujirebio Inc.
9.7 WuXi AppTec Co., Ltd.
9.8 NorthEast BioAnalytical Laboratories LLC.
9.9 Celerion, Inc.
9.10 GenScript ProBio Co., Ltd.
